4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000076
Chief Medical Officer sold 20,406 shares at an average $26.89 ($548,672)
- Chief Medical Officer acquired 14,058 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-04-13 | Option exercise 10b5-1 | +6,349 | $1.08 | $6,857 | 82,489 | D |
| Rodman David Malcom Chief Medical Officer | 2026-04-13 | Option exercise 10b5-1 | +3,542 | $10.20 | $36,128 | 86,031 | D |
| Rodman David Malcom Chief Medical Officer | 2026-04-13 | Option exercise 10b5-1 | +4,167 | $14.25 | $59,380 | 90,198 | D |
| Rodman David Malcom Chief Medical Officer | 2026-04-13 | Sale 10b5-1 | −14,058 | $26.54 | $373,087 | 76,140 | D |
| Rodman David Malcom Chief Medical Officer | 2026-04-15 | Sale 10b5-1 | −6,348 | $27.66 | $175,586 | 69,792 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-04-13 | Option exercise · Stock Option 10b5-1 | −6,349 | 19,046 | D | ||
| Rodman David Malcom Chief Medical Officer | 2026-04-13 | Option exercise · Stock Option 10b5-1 | −3,542 | 120,417 | D | ||
| Rodman David Malcom Chief Medical Officer | 2026-04-13 | Option exercise · Stock Option 10b5-1 | −4,167 | 91,667 | D | ||
| Open-market sales · 20,406 sh · avg $26.89 · $548,672 | |||||||
Loading xslF345X06/wk-form4_1776303923.xml…